Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization: NASPI Study-A Randomized Controlled Trial

NCT00356954 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT00356954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00356954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization: NASPI Study-A Randomized Controlled Trial
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2005
Completion date
April 30, 2006
Enrollment
250
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure